Guardant Health Newsroom

Guardant Health, ConcertAI Collaborate On Agreement That Allows Biopharmaceutical Companies To Access The First Multi-Modal Real-World Data That Integrates Comprehensive Patient Electronic Medical Record Data With Both Genomic And Epigenomic Tumor...

BenzingaJan 16 08:15 ET

Express News | Guardant Health Inc - Financial Terms of Agreement Not Disclosed

ReutersJan 16 08:05 ET

Guardant Health, ConcertAI Collaborate to Form First Data-As-A-Service That Integrates Clinical and Tumor Profiling Data to Accelerate Cancer Therapy Research and Development

BusinesswireJan 16 08:05 ET

Express News | Guardant Health, Concertai Collaborate to Form First Data-as-a-Service That Integrates Clinical and Tumor Profiling Data to Accelerate Cancer Therapy Research and Development

ReutersJan 16 08:05 ET

Express News | Viz.ai to Collaborate With Guardant Health to Improve Lung Cancer Detection, Diagnosis, and Treatment

ReutersJan 14 15:58 ET

Express News | Viz.ai Reveals Proposed Collaboration With Guardant Health

BenzingaJan 14 15:57 ET

Craig-Hallum Maintains Guardant Health(GH.US) With Buy Rating

Moomoo NewsJan 14 09:33 ET · Ratings

A Quick Look at Today's Ratings for Guardant Health(GH.US), With a Forecast Between $42 to $42

Moomoo NewsJan 14 08:00 ET · Ratings

Guardant Health: Strong Financial Performance and Growth Potential Justify Buy Rating

TipRanksJan 13 20:09 ET

Guardant Health Reports Revenue Growth Amid Cash Flow Losses

TipRanksJan 13 16:48 ET

Guardant Health | 8-K: Guardant Health Announces Preliminary Fourth Quarter and Full Year 2024 Results

SECJan 13 16:22 ET · Announcements

Guardant Health (GH) Gets a Buy From Craig-Hallum

TipRanksJan 13 09:05 ET · Ratings

Guardant Health Announced Preliminary FY2024 Sales Of Approximately $737M, An Increase Of 31% Compared To Consensus Of $723.9M

BenzingaJan 13 07:09 ET

Express News | Guardant Health Q4 Revenue USD 200 Million Vs. IBES Estimate USD 186.7 Million

ReutersJan 13 07:00 ET

Press Release: Guardant Health Announces Preliminary Fourth Quarter and Full Year 2024 Results

Dow JonesJan 13 07:00 ET

Plug Power, Capri And Frontline Are Among Top Mid Cap Gainers Last Week (Jan 6-10): Are The Others In Your Portfolio?

BenzingaJan 12 09:47 ET

UBS Maintains Guardant Health(GH.US) With Buy Rating, Maintains Target Price $40

Moomoo NewsJan 10 17:31 ET · Ratings

Guardant Health Holds 'Underappreciated' Catalyst Path, UBS Says

MT NewswiresJan 10 15:12 ET

Bernstein Maintains Guardant Health(GH.US) With Buy Rating, Raises Target Price to $45

Moomoo NewsJan 10 13:31 ET · Ratings

Jefferies Maintains Guardant Health(GH.US) With Buy Rating, Maintains Target Price $42

Moomoo NewsJan 8 08:31 ET · Ratings